About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Dr Anita Raja, GP and TV presenter, said: “When compared to modern weight-loss injections, such as GLP-1 receptor agonists, ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...